MedPath
NMPA Approval

Chlorzoxazone Tablets

国药准字H14023710

January 28, 2022

国药准字H14023710

Drug Information

氯唑沙宗片

千汇

片剂

0.2g

化学药品

January 28, 2022

Company Information

Applicant Company

山西省太原经济技术开发区生物医药园(唐明路42号)

Manufacturing Company

山西省太原经济技术开发区生物医药园(唐明路42号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯唑沙宗片 - NMPA 批准文号 | MedPath